Treat to Target a largo plazo?

Long-Term Advantages May Not Last Following Tight Control In Psoriatic Arthritis, Study Suggests

Rheumatology News (9/11, Splete) reports, "Patients with psoriatic arthritis who participated in a tight control program for 48 weeks showed no clinical advantage over patients who received usual care when reviewed again five years after having gone back to standard rheumatology care outside of the study," research indicated. The findings, which were "based on data from 110 patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) study," were published online in the journal Rheumatology

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.